Paper42514865
Copper Complexes: Emerging Micro- and Nanosystems for Dermatological Treatment.
Hernández-Rojas I and 6 others. Pharmaceutics, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Copper Complexes: Emerging Micro- and Nanosystems for Dermatological Treatment. Papers, record 42514865. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42514865
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References190
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34210051 | Copper as Dietary Supplement for Bone Metabolism: A Review. | Nutrients | 2021 | https://conductscience.org/library/papers/34210051 | PubMed |
| 2 | 26778425 | Sequence proximity between Cu(II) and Cu(I) binding sites of human copper transporter 1 model peptides defines reactivity with ascorbate and O2. | J Inorg Biochem | 2016 | https://conductscience.org/library/papers/26778425 | PubMed |
| 3 | 29758074 | Comparison of the effect of dietary copper nanoparticles and one copper (II) salt on the copper biodistribution and gastrointestinal and hepatic morphology and function in a rat model. | PLoS One | 2018 | https://conductscience.org/library/papers/29758074 | PubMed |
| 4 | 36430330 | The Role of Copper Homeostasis in Brain Disease. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36430330 | PubMed |
| 5 | 20053132 | Stimulation of cell proliferation and expression of matrixmetalloproteinase-1 and interluekin-8 genes in dermal fibroblasts by copper. | Connect Tissue Res | 2010 | https://conductscience.org/library/papers/20053132 | PubMed |
| 6 | 41365377 | Local therapy with hypoxia-targeting radiopharmaceutical [64Cu]Cu-ATSM in high-grade glioma patient-derived xenograft models. | Radiother Oncol | 2026 | https://conductscience.org/library/papers/41365377 | PubMed |
| 7 | 38507993 | A new copper(II) complex containing long-chain aliphatic hydrazide and 1,10-phenanthroline upregulates ADP hydrolysis in triple-negative breast cancer cells. | J Inorg Biochem | 2024 | https://conductscience.org/library/papers/38507993 | PubMed |
| 8 | 31252311 | Preclinical Pharmacokinetic and Safety Studies of Copper-Diacetyl-Bis(N4-Methylthiosemicarbazone) (Cu-ATSM): Translational Studies for Internal Radiotherapy. | Transl Oncol | 2019 | https://conductscience.org/library/papers/31252311 | PubMed |
| 9 | 29280540 | Contact killing and antimicrobial properties of copper. | J Appl Microbiol | 2018 | https://conductscience.org/library/papers/29280540 | PubMed |
| 10 | 42070829 | The dissemination of antibiotic resistance genes and heavy metal resistance genes along the sewage pipe under Cu and Zn stress. | J Environ Sci (China) | 2026 | https://conductscience.org/library/papers/42070829 | PubMed |
| 11 | 37356379 | Evaluation of azothioformamides and their copper(I) and silver(I) complexes for biological activity. | J Inorg Biochem | 2023 | https://conductscience.org/library/papers/37356379 | PubMed |
| 12 | 41695949 | Synergistic bactericidal activity of a ginsenoside-copper nano-agent against gram-positive and gram-negative biofilm bacteria. | Front Microbiol | 2026 | https://conductscience.org/library/papers/41695949 | PubMed |
| 13 | 19402880 | Copper homeostasis. | New Phytol | 2009 | https://conductscience.org/library/papers/19402880 | PubMed |
| 14 | 41224798 | Shikonin-copper coordination nanoparticles for enhanced antibacterial and antibiofilm activity against Staphylococcus aureus. | Sci Rep | 2025 | https://conductscience.org/library/papers/41224798 | PubMed |
| 15 | 39970778 | Copper in melanoma: At the crossroad of protumorigenic and anticancer roles. | Redox Biol | 2025 | https://conductscience.org/library/papers/39970778 | PubMed |
| 16 | 33900531 | Copper biodistribution after acute systemic administration of copper gluconate to rats. | Biometals | 2021 | https://conductscience.org/library/papers/33900531 | PubMed |
| 17 | 34437513 | State of the Art on Toxicological Mechanisms of Metal and Metal Oxide Nanoparticles and Strategies to Reduce Toxicological Risks. | Toxics | 2021 | https://conductscience.org/library/papers/34437513 | PubMed |
| 18 | 36934611 | DDTC-Cu(I) based metal-organic framework (MOF) for targeted melanoma therapy by inducing SLC7A11/GPX4-mediated ferroptosis. | Colloids Surf B Biointerfaces | 2023 | https://conductscience.org/library/papers/36934611 | PubMed |
| 19 | 36163613 | Copper-Curcumin-Bipyridine Dicarboxylate Complexes as Anticancer Candidates. | Chem Biodivers | 2022 | https://conductscience.org/library/papers/36163613 | PubMed |
| 20 | 39408444 | Copper Nanoparticle Loaded Electrospun Patches for Infected Wound Treatment: From Development to In-Vivo Application. | Polymers (Basel) | 2024 | https://conductscience.org/library/papers/39408444 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42514865
GET https://conductscience.org/api/papers/v1/42514865/references?page=2